Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
APGE
APGE News & Events
-
Add to Watchlist
Trade APGE Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
APGE News
Valuation Analysis of Mid-Cap U.S. Healthcare Stocks
Jun 02 2026
seekingalpha
Regulatory Approvals and Collaborations in Biotech Sector
May 29 2026
NASDAQ.COM
Wedbush Raises Apogee Therapeutics Price Target to $135 Amid Positive Trial Results
May 28 2026
NASDAQ.COM
Apogee Secures $1.3B Financing to Advance Skin Therapy
May 27 2026
seekingalpha
Apogee Therapeutics Reports Positive Phase 2 APEX Trial Data for Zumilokibart
May 27 2026
NASDAQ.COM
Apogee Therapeutics Secures Up to $1.3 Billion Financing Partnership with Blackstone
May 27 2026
NASDAQ.COM
Apogee Therapeutics Partners with Blackstone for $1.3B Financing
May 27 2026
seekingalpha
Apogee Secures Up to $1.3 Billion in Financing for Zumilokibart Development
May 27 2026
Newsfilter
Show More News
APGE Events
No data
APGE Monitor News
Apogee Therapeutics faces valuation concerns amid market fluctuations
Jun 04 2026
Apogee Secures $1.3 Billion Financing for Zumilokibart Development
May 29 2026
Apogee Secures $1.3 Billion Financing for Zumilokibart Development
May 27 2026
Apogee Therapeutics Prices Public Offering at $70 per Share
Mar 25 2026
Apogee Therapeutics Reports Positive Phase 2 Results for Zumilokibart
Mar 23 2026
No relevant news for Apogee Therapeutics Inc.
Jan 23 2026
APGE Earnings Analysis
No Data
People Also Watch
